Platelet‐Rich Plasma Treatment for Accelerated Androgenetic Alopecia Pattern Hair Loss After COVID‐19 Infection: A Case Series

Background Hair‐related manifestations such as alopecia areata or telogen effluvium were reported during COVID‐19 disease. Accelerated hair loss with androgenetic alopecia (AGA) pattern or management has not been discussed before. Aims This study aimed to examine the accelerated AGA pattern hair los...

Full description

Saved in:
Bibliographic Details
Published inJournal of Cosmetic Dermatology Vol. 21; no. 2; pp. 590 - 594
Main Authors İşlek, Akif, Karaaslan, Engin, Şimşek, Sadullah, Merve Çetin, Funda
Format Journal Article Web Resource
LanguageEnglish
Published England John Wiley & Sons, Inc 01.02.2022
Subjects
Online AccessGet full text

Cover

Loading…
More Information
Summary:Background Hair‐related manifestations such as alopecia areata or telogen effluvium were reported during COVID‐19 disease. Accelerated hair loss with androgenetic alopecia (AGA) pattern or management has not been discussed before. Aims This study aimed to examine the accelerated AGA pattern hair loss and management with PRP treatment. Materials and Methods This study was designed prospectively and nine patients included to study confirmed PCR test for COVID‐19 infection. Patients underwent platelet‐rich plasma (PRP) injections for 4 sessions. Results were accessed with the hair pull test (HPT) and self‐administered hair growth questionnaire (HGQ). Results Nine patients were admitted with complaints of hair loss after an average of 220 ± 24.2 (min: 182 max: 264) day after recovery of COVID‐19. Mean age of the patients was 33.8 ±8.4 years old (min: 26, max: 52). Six (66.7%) patients were male, and three (33.3%) of them were female. HPT score decreased to 6.0 ± 1.6 after the first PRP application (p = 0.007, CI 95%:2.7–5.2) and decreased to 1.2 ± 0.8 after the last PRP session (p = 0.008, CI 95%: 6.4–11.1). Five (55.5%) of the patients described the treatment as “very effective” after treatment with HGQ. Conclusions Accelerated hair loss associated with COVID‐19 continues in long term and PRP treatment provides a satisfactory solution.
Bibliography:Funding information
This research did not receive any specific grant from funding agencies in the public, commercial, or notfor‐profit sectors
ObjectType-Article-1
SourceType-Scholarly Journals-1
ObjectType-Feature-2
content type line 23
ISSN:1473-2130
1473-2165
DOI:10.1111/jocd.14721